Last reviewed · How we verify

Paracetamol + ibuprofen

Ullevaal University Hospital · FDA-approved active Small molecule

Paracetamol and ibuprofen work synergistically to reduce pain and fever through complementary analgesic and anti-inflammatory pathways.

This combination product uses paracetamol to reduce fever and pain via central nervous system effects, and ibuprofen to inhibit cyclooxygenase enzymes, reducing inflammation and pain. Used for Mild to moderate pain, Fever reduction.

At a glance

Generic nameParacetamol + ibuprofen
Also known asIbumetin, Ibuprofen, ATC code: M01A E01, Paracetamol, Acetaminophen
SponsorUllevaal University Hospital
Drug classAnalgesic/antipyretic combination
TargetCOX-1, COX-2 (ibuprofen); prostaglandin synthesis pathway (paracetamol)
ModalitySmall molecule
Therapeutic areaPain management, Fever reduction
PhaseFDA-approved

Mechanism of action

Paracetamol inhibits prostaglandin synthesis in the central nervous system, reducing pain perception and fever. Ibuprofen is a non-selective COX inhibitor that reduces prostaglandin production peripherally and centrally, providing anti-inflammatory, analgesic, and antipyretic effects. The combination leverages both central and peripheral mechanisms for enhanced pain relief.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: